EMCURE PHARMACEUTICALS LIMITED : CORPORATE FILING - DECLARATION UNDER SEBI REGULATIONS

• Promoters declared no encumbrance on equity shares during FY ended March 31, 2026. • Mrs. Smita Paresh Shah, part of promoter group, had pledged 60,000 equity shares during FY 2024-25, which remain pledged. • Persons acting in concert, including promoter group, total 41 entities and individuals. • Date of declaration is April 02, 2026. Impact: Neutral (Routine regulatory filing regarding share encumbrances)

Emcure Pharmaceuticals Limited

Open attachment

← Back to feed